Perelman School of Medicine

Making history at LDI: An interview with Rachel Werner

Rachel Werner is the first female and first physician-economist executive director of the Leonard Davis Institute of Health Economics, and a professor of both medicine at the Perelman School of Medicine and health care management at the Wharton School.

Penn Today Staff

How to quell a cytokine storm

An international team finds new ways to dampen an overactive immune system, and can influence new drug targets for lupus and other autoimmune disorders.

Penn Today Staff

Eczema’s effect on children differs by race

A Penn study finds racial disparities in school attendance due to common skin condition, with Hispanic and black children more likely to miss school due to eczema than white children.

Penn Today Staff



In the News


Time

‘They’re chipping away.’ Inside the grassroots effort to fight mandatory vaccines

In an article about anti-vax organizing, Paul Offit of the Perelman School of Medicine said, “Vaccines are a victim of their own success.” Offit continued, “people have forgotten how sick measles can make you and how dead measles can make you.”

FULL STORY →



Nature

Whole-body PET scanner produces 3D images in seconds

Abass Alavi of the Perelman School of Medicine spoke about a new version of a PET scanner that can generate 3D renderings of the entire human body in just seconds, a fraction of the time required by older iterations. “The whole-body machine is another quantum jump in medical imaging,” said Alavi.

FULL STORY →



Philadelphia Inquirer

10-year-old’s cholesterol was over 800. Can CRISPR fix the problem?

Kiran Musunuru of the Perelman School of Medicine, who is a partner in a biotech start-up with labs housed at Pennovation Works, spoke about the potential benefits of CRISPR gene-editing for patients with heart disease. A trial for a similar therapy developed by a different team is currently underway at the Abramson Cancer Center.

FULL STORY →



Philadelphia Inquirer

How conquering a rare leukemia in children revolutionized cancer care for millions

Carl June of the Perelman School of Medicine was mentioned for his contributions to the field of cancer research.

FULL STORY →



Philadelphia Inquirer

Philly’s biotech leaders pitched the city at Bio 2019 to CEOs and some even seemed impressed

Carl June of the Perelman School of Medicine participated in BIO 2019, an international biotechnology conference hosted in Philadelphia. Speaking about the change in resources for gene therapy research over time, June said “a lot of ideas used to die because we didn’t have the money to test. Now, that’s over.”

FULL STORY →